Small Business Innovation Research (SBIR) program, Phase I
Agency: Administration for Community Living
Assistance Listings: 93.433 -- ACL National Institute on Disability, Independent Living, and Rehabilitation Research
Description
The purpose of the Federal SBIR program is to stimulate technological innovation in the private sector, strengthen the role of small business in meeting Federal research or research and development (R/R&D) needs, and improve the return on investment from Federally-funded research for economic and social benefits to the nation. The specific purpose of ACL's SBIR program is to improve the lives of people with disabilities through R/R&D products generated by small businesses, and to increase the commercial application of ACL-supported research results and development products. Phase I SBIR grants are intended to conduct research to determine the scientific or technical merit and feasibility of concepts, topics, or ideas. NIDILRR will make 10 grants under this opportunity. Grants will have a 6-month project period with a corresponding six-month budget period.
Eligibility
Eligible applicants
Business
- Small businesses
Additional information
Grantor contact information
Description
brian.bard@acl.hhs.gov
Documents
No documents are currently available.
Link to additional information
Forecasted
Estimated Post Date:
October 15, 2025
Estimated Application Due Date:
December 15, 2025
Estimated Due Date Description:
Not available
Estimated Award Date:
June 1, 2026
Estimated Project Start Date:
June 1, 2026
Fiscal Year:
2026
Award
$1,000,000
Program Funding
10
Expected awards
$95,000
Award Minimum
$100,000
Award Maximum
Funding opportunity number:
HHS-2026-ACL-NIDILRR-BISA-0207
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Science technology and other research and development
Category Explanation:
History
Version:
1
Forecast posted date:
September 5, 2025
Archive date:
September 30, 2026
